This is a preview. Log in through your library . Abstract The goal of this study was to determine the role of the Janus tyrosine kinase (JAK)-signal transducers and activators of transcription (STAT) ...
Please provide your email address to receive an email when new articles are posted on . NEW YORK — Systemically administered Janus kinase inhibitors hold potential for the treatment of alopecia areata ...
Researchers have gained a deeper understanding of the nuanced roles of JAK inhibitors, or modulators, in inflammation across various cell types and tissues. Researchers at the Icahn School of Medicine ...
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences, discusses ...
-Reported Lack of Blood and Platelet Side Effects Provides Attractive Regulatory and Commercial Profile over other JAK inhibitors, -Conference Call Scheduled, Today at 8:30 A.M. Eastern Time SEATTLE ...
Positron emission tomography (PET) and estrogen receptor (ER) ligand in patients with invasive breast cancer. Germline single nucleotide polymorphisms (SNPs) in XRCC3, XRCC1, and XPD, and survival ...
Acute myeloid leukemia (AML) is a deadly hematologic malignancy with poor prognosis, particularly in the elderly. Even among individuals with favorable-risk disease, approximately half will relapse ...
Paul Friedman, chief executive of Incyte, believes that a newly-inked collaborative and licensing deal with Novartis for INCB18424, an oral JAK1/JAK2 inhibitor entering late-stage development for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback